top of page

Talking oncology targets (EGFR, FLT3, B7H4 and more) with Cullinan Oncology

Cullinan Oncology CEO Nadim Ahmed walks us through the oncology targets the company is focused on and discusses recent ASCO data.



Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page